About
JEL delivery technology
Areas of Focus
Categories
Drug Delivery & FormulationSan Diego & Southern California
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
89
By Phase
PHASE1: 3PHASE1/PHASE2: 3
By Status
COMPLETED: 4ACTIVE_NOT_RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05698329Lead Sponsor
Effect of AIV007 by Periocular Administration in Subjects with Macular Edema Secondary to Neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME)
PHASE1Active, not recruiting
19 participants
Started: Mar 2, 2023 · Completed: Apr 1, 2025
NCT03883945Lead Sponsor
A Safety and Efficacy Study to Evaluate Rosacea
PHASE1/PHASE2Withdrawn
Started: Jul 31, 2021 · Completed: Aug 31, 2022
NCT04827875Lead Sponsor
Safety and Efficacy of AIV001 on Scar Formation and Keloid Recurrence Following Keloidectomy
PHASE1Completed
25 participants
Started: Jun 23, 2021 · Completed: Dec 15, 2022
NCT04422899Lead Sponsor
Effect of Intravitreally Administered AIV007 in Subjects With Neovascular Age-Related Macular Degeneration
PHASE1Completed
3 participants
Started: Aug 28, 2020 · Completed: Feb 28, 2022
NCT04470726Lead Sponsor
Safety and Efficacy Evaluation of AIV001 in Nonmelanoma Skin Cancer of the Low Risk Basal Cell Carcinoma Subtype
PHASE1/PHASE2Completed
26 participants
Started: Aug 18, 2020 · Completed: Jul 28, 2023
Locations (1)
Headquarters
Irvine, CA, United States
Map
Loading map...